DOCSLIB.ORG

Ofer-Purim-CV.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ofer-Purim-CV.Pdf CURRICULUM VITAE 1. Personal Details Family name, first name: Purim Ofer Date & place of birth: February 10, 1970, Israel Address (Office): Department of Oncology, Assuta Academic Hospital, Ashdod 7747629, Israel (Residence): 6 Wengrover Street, Petach Tikva, Israel Telephone number (Office): +972-72-3398127 (Residence): +972-77-2002848 Cellular phone number: +972-52-4841199 Fax number: +972-72-3399087 E-mail address: [email protected] 2. Academic Education 1992-1995 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Subject: Life Sciences BSc degree 1996-1998 School of Dentistry, Tel Aviv University, Tel Aviv, Israel 1998-2002 University of Szeged, Szeged, Hungary Subject: Medicine MD degree [Cum Laude] Title of Doctoral Dissertation: Identification of sentinel node with gamma probe with technetium in melanoma patients 3. Professional Training 2003 Internship, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel 2004-2010 Resident in Institute of Oncology, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel 2008 GCP course, Shefayim, Israel 3. Professional Training 2010-2017 Attending Physician, Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel Since 11/17 Head of Gastrointestinal Malignancy Service, Assuta Academic Hospital, Ashdod, Israel 4. Board Certification Passed Oncology Step A 2007 Passed Oncology Step B 2009 Oncology Specialty 2009 5. Professional Licensing Medical License #37134 2002 Specialty License #28470 2009 6. Employment History Year Position Department Institution 2003 Internship Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel 2004-2010 Resident Institute of Oncology Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel 2010-2017 Attending Institute of Oncology Rabin Medical Center – Physician Beilinson Hospital, Petach Tikva, Israel Since Nov 2017 Head Gastrointestinal Assuta Academic Hospital, Malignancy Service Ashdod, Israel 7. Academic Appointments Year Title (Rank) Department Faculty University 2006 Tutor Oncology Sackler Tel Aviv University 9. Membership in Professional/Scientific Societies Year Name of Society 2004 Israel Medical Association 2005 Israel Society of Clinical Oncology and Radiotherapy 2010 American Society of Clinical Oncology 11. Additional Functions (Committee memberships, academic and administrative functions) Year Function Since 2008 Gave Frontal Lectures to Family Physicians, Nurses, Oncological Residents, Pharmacists 13. Scientific Publications Hindex h-index 6 Sum of Times Cited 252 Without self citations 247 Refereed articles in scientific journals 1. Articles Published 1. Kundel Y*, Purim O*, Figer A, Stemmer SM, Tichler T, Sulkes J, Sulkes A, Brenner B. (*Equal Contribution) Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer. Med Sci Monit. 2008 Apr;14(4):CR190-5. (MEDICINE, RESEARCH & EXPERIMENTAL JR 89/128, Q3, IF 1.585, CI 1) 2. Joachims Z, Feinmesser R, Purim O, Halpern M, Brenner B, Fenig E, Roizman P, Sulkes J, Feinmesser M. Cyclooxygenase-2 expression in primary and metastatic Merkel cell carcinoma. Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):442-6. (ANATOMY & MORPHOLOGY JR 8/21, Q2, IF 1.634, CI 4) 3. Kundel Y, Brenner R, Purim O, Peled N, Idelevich E, Fenig E, Sulkes A, Brenner B. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option? Dis Colon Rectum. 2010 Dec;53(12):1624-31. (SURGERY JR 32/197, Q1, IF 3.519, CI 43) 4. Brenner B*, Hoshen MB*, Purim O*, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. (*Equal Contribution) MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011 Sep 21;17(35):3976-85. (GASTROENTEROLOGY & HEPATOLOGY JR 30/79, Q2, IF 3.365, CI 76) 5. Kundel Y*, Purim O*, Idelevich E, Lavrenkov K, Man S, Kovel S, Karminsky N, Pfeffer RM, Nisenbaum B, Fenig E, Sulkes A, Brenner B. (*Equal Contribution) Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? A retrospective multi-institutional study. Radiat Oncol. 2011 Sep 29;6:127. (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING JR 38/127, Q2, IF 2.568, CI 9) 6. Dreznik A, Purim O, Idelevich E, Kundel Y, Sulkes J, Sulkes A, Brenner B. Gastric cancer: biology and clinical manifestations in Israel. J Surg Oncol. 2012 Mar;105(3):316-22. (SURGERY JR 43/197, Q1, IF 2.993, CI 3) 1. Articles Published 7. Ben Aharon I*, Purim O*, Kundel Y, Brenner R, Gordon N, Sulkes A, Brenner B. (*Equal Contribution) The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience. Anticancer Drugs. 2012 Mar;23(3):313-20. (PHARMACOLOGY & PHARMACY JR 135/257, Q3, IF 2.320, CI 5) 8. Rath-Wolfson L, Purim O, Ram E, Morgenstern S, Koren R, Brenner B. Expression of estrogen receptor β1 in colorectal cancer: correlation with clinicopathological variables. Oncol Rep. 2012 Jun;27(6):2017-22. (ONCOLOGY JR 125/217, Q3, IF 2.662, CI 5) 9. Weissmann-Brenner A, Kushnir M, Lithwick Yanai G, Aharonov R, Gibori H, Purim O, Kundel Y, Morgenstern S, Halperin M, Niv Y, Brenner B. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer. Int J Oncol. 2012 Jun;40(6):2097-103. (ONCOLOGY JR 105/217, Q2, IF 3.079, CI 39) 10. Goldberg N*, Kundel Y*, Purim O*, Bernstine H, Gordon N, Morgenstern S, Idelevich E, Wasserberg N, Sulkes A, Groshar D, Brenner B. (*Equal Contribution) Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study. Radiat Oncol. 2012 Aug 1;7:124. (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING JR 38/127, Q2, IF 2.568, CI 19) 11. Purim O, Gordon N, Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit. 2013 Mar 20;19:203-9. (MEDICINE, RESEARCH & EXPERIMENTAL JR 89/128, Q3, IF 1.585, CI 20) 12. Purim O*, Kundel Y*, Shapira R, Tichler T, Brenner B. (*Equal Contribution) Dose-Dense Regimen of Cisplatin and Infusional Fluorouracil in Advanced Gastric Cancer: A Single Institution Experience. J Cancer Therapy. 2013 Apr;4(2):529-35. (No IF, CI ) 1. Articles Published 13. Kundel Y, Nasser NJ, Purim O, Yerushalmi R, Fenig E, Pfeffer RM, Stemmer SM, Rizel S, Symon Z, Kaufman B, Sulkes A, Brenner B. Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin. PLoS One. 2013 Jul 10;8(7):e68327. (MULTIDISCIPLINARY SCIENCES JR 15/64, Q1, IF 2.806, CI 1) 14. Brenner RM, Kivity S, Kundel Y, Purim O, Peled N, Idelevich E, Lavrenkov K, Kovel S, Fenig E, Sulkes A, Brenner B. Ethnic variation in toxicity and outcome of adjuvant chemoradiation for gastric cancer in Israel. Anticancer Res. 2013 Nov;33(11):5151-7. (ONCOLOGY JR 161/217, Q3, IF 1.937, CI 0) 15. Dickman R, Kundel Y, Levy-Drummer R, Purim O, Wasserberg N, Fenig E, Sulkes A, Brenner B. Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study. Radiat Oncol. 2013 Nov 29;8:278. (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING JR 38/127, Q2, IF 2.568, CI 4) 16. Berger Y, Zbar AP, Lebedyev A, Levi Y, Nevler A, Aderka D, Golan T, Purim O, Brenner B, Natur M, Gutman M. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin]. Harefuah. 2014 Jun;153(6):315-9, 368. (No IF, CI ) 17. Vilkin A, Halpern M, Morgenstern S, Brazovski E, Gingold-Belfer R, Boltin D, Purim O, Kundel Y, Welinsky S, Brenner B, Niv Y, Levi Z. How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation? Hum Pathol. 2014 Oct;45(10):2029-36. (PATHOLOGY JR 18/79, Q1, IF 3.014, CI 5) 18. Wasserberg N, Kundel Y, Purim O, Keidar A, Kashtan H, Sadot E, Fenig E, Brenner B. Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy. Radiat Oncol. 2014 Oct 22;9:233. (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING JR 38/127, Q2, IF 2.568, CI 1) 1. Articles Published 19. Epelbaum R, Shacham-Shmueli E, Klein B, Agbarya A, Brenner B, Brenner R, Gez E, Golan T, Hubert A, Purim O, Temper M, Tepper E, Voss A, Russell K, Dvir A, Soussan-Gutman L, Stemmer SM, Geva R. Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study. Biomed Res Int. 2015;2015:681653. (BIOTECHNOLOGY & APPLIED MICROBIOLOGY JR 67/160, Q2, IF 2.476, CI 1) 20. Wasserberg N*, Purim O*, Bard V, Kundel Y, Gordon N, Groshar D, Goldberg N, Kashtan H, Sulkes A, Brenner B. (*Equal Contribution) Early postoperative 18F-FDG PET/CT in high-risk stage III colorectal cancer. Clin Nucl Med. 2015 Apr;40(4):e222-7. (RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING JR 12/127, Q1, IF 4.563, CI 3) 21. Levi M, Shalgi R, Brenner B, Perl G, Purim O, Amit L, Stemmer SM, Ben- Aharon I. The impact of oxaliplatin on the gonads: from bedside to the bench. Mol Hum Reprod. 2015 Dec;21(12):885-93. (OBSTETRICS & GYNECOLOGY JR 10/80, Q1, IF 3.585, CI 2) 22. Brenner B, Geva R, Rothney M, Beny A, Dror Y, Steiner M, Hubert A, Idelevich E, Gluzman A, Purim O, Shacham-Shmueli E, Shulman K, Mishaeli M, Man S, Soussan-Gutman L, Tezcan H, Chao C, Shani A, Liebermann N. Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients. Value Health. 2016 Jan;19(1):82-7. (HEALTH CARE SCIENCES & SERVICES JR 10/90, Q1, IF 4.235, CI 2) 23.
Load more

Recommended publications
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Dear Colleagues, It Is Our Pleasure to Invite You to the Annual Meeting Of
    Dear Colleagues, It is our pleasure to invite you to the Annual Meeting of the Israel Neurosurgical Society which will be held at the Galilion Hotel, Israel. Although the main focus of the meeting will be Brain Tumors, the organizers will be happy to consider interesting talks on related subjects. Confirmed speakers to date that will share their experiences and update us in the latest developments include: Prof. Volker A. Coenen Dept. of Stereotactic and Functional Neurosurgery, University of Freiberg; Neurosurgery Clinic, Freiberg, Germany Prof. Garth Rees Cosgrov Dept. of Neurological Surgery, Brigham and Women's Hospital, Boston, MA, USA Prof. Hans Henkes Neuroradiological Clinic, Katharinenhospital, Stuttgart, Germany Prof. Robert H. Rosenwasser Dept. of Neurological Surgery, Jefferson Hospital for Neuroscience, Philadelphia, PA, USA As in previous meetings, we hope that this event will provide the opportunity to reconnect and meet with colleagues and to strengthen professional and personal ties among our members. We hope that you will be able to join us. Sincerely, Prof. Yigal Shoshann Prof. Mony Benifla Dr. Racheli Grossman President Secretary Treasurer 1 TENTATIVE TIMETABLE Wednesday, May 13, 2020 Light Lunch Afternoon Sessions Dinner Evening Social Event Thursday, May 14, 2020 Morning Sessions Lunch Afternoon Sessions Dinner Evening Social Event Friday, May 15, 2020 Morning Sessions Afternoon Sessions End and Light Lunch Meeting Secretariat Target Conferences Ltd. PO Box 51227, Tel Aviv 6713818, Israel Tel: +972 3 5175150, Fax: +972 3 5175155 e-mail: [email protected] www.israelneurosurgery.com 2 SCIENTIFIC ADVISORY COMMITTEE ON FUNCTIONAL NEUROSURGERY AND EPILEPSY Zvi Israel - Lead Advisor Dept. of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem Roberto Spiegelmann Dept.
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program
    January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H.
    [Show full text]
  • Rabin Medical Center a Long Tradition of Excellence Rabin Medical Center
    RABIN MEDICAL CENTER A LONG TRADITION OF EXCELLENCE RABIN MEDICAL CENTER Rabin Medical Center (RMC), in the vanguard of Israel’s healthcare system, is one of the country’s leading medical institutions, renowned for its superior level of patient care. Home to several centers of excellence, it has earned a world- class reputation for its cutting-edge treatments, advanced medical technologies, pioneering medical research and a holistic approach to patient care. Ideally located in the center of the country, Rabin Medical Center is a major tertiary referral center for patients from all over Israel and abroad. As a public hospital, RMC provides equal access to healthcare to patients from all of Israel’s diverse religious and cultural population groups. The establishment of Beilinson Hospital in 1936 was an important milestone in the development of the Jewish Settlement in the Land of Israel. The new hospital was intended to serve the pioneers in the surrounding regions. The Hasharon Hospital was founded in 1942 with the growing need for medical services. Rabin Medical Center, named in memory of the late Prime Minister Yitzhak Rabin, was created in 1996 as a result of the merging of Beilinson and Hasharon Hospitals. With both hospitals enjoying a long and proud tradition of providing compassionate and outstanding patient care to the citizens of Israel, the Center is distinguished as one of Israel’s largest and most prestigious medical facilities. PRESTIGIOUS TEACHING HOSPITAL Affiliated with the Tel Aviv University - Sackler School of Medicine, RMC has earned a nationwide reputation as a prestigious teaching hospital for interns, residents and fellows in all fields of medicine, with many staff members holding academic positions.
    [Show full text]
  • 1. Personal Details 2. Academic Education
    Avishag Laish-Farkash, MD, PhD 1 CURRICULUM VITAE AND LIST OF PUBLICATIONS 1. Personal Details Family name, first name: Laish-Farkash Avishag Date and place of birth: 28 April 1970, Israel Address (Office): Arrhythmia and Pacing Unit, Cardiology department, Assuta Ashdod University Medical Center, Ashdod (Residence): 5 Haavoda street, Givat-Shmuel 5402309, Israel Telephone number (Residence): 077-7897808 Cellular phone number: 053-7678726 Fax number: (home) 03-751-5494 E-mail address: [email protected]; [email protected] 2. Academic Education B.Sc. Med Sackler School of Medicine, Tel-Aviv University, Israel Date award: 8.1991 M.D. degree Sackler School of Medicine, Tel-Aviv University, Israel Date award: 6.1996 Title of M.D. Thesis: “The Natural Course of Erythrocyte Sedimentation Rate and Non-Specific Acute Phase Reactants after Cardiac Surgery”. Names of Supervisors: Meir Lahav, M.D., Medicine Department E, Sapir Medical Center, Kfar-Saba, and Arie Regev, M.D., Medicine Department E, Beilinson Campus, Rabin Medical Center, Petach-Tiqva. Ph.D. Sackler School of Medicine, Tel-Aviv University, Israel Date award: 2/2004 Title of Ph.D. Thesis: “Congenital Long QT Syndrome: Molecular and Electrophysiological Evaluation of a New SCN5A Mutation in a Large Israeli Pedigree”. Names of Supervisors: Prof. Michael Eldar, M.D., Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, and Prof. Ilana Lotan, Ph.D., The Avishag Laish-Farkash, MD, PhD 2 Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University. 3. Professional Training 1.1.95 –31.12.95 Internship, Beilinson campus, Rabin Medical Center, Petach-Tiqva, Israel.
    [Show full text]
  • Hyperemesis Gravidarum in Northern Israel: a Retrospective Epidemiological Study Tom Konikoff1,4*, Tehila Avraham2, Ella Ophir1,3 and Jacob Bornstein1,3
    Konikoff et al. Israel Journal of Health Policy Research (2016) 5:39 DOI 10.1186/s13584-016-0100-9 ORIGINAL RESEARCH ARTICLE Open Access Hyperemesis gravidarum in northern Israel: a retrospective epidemiological study Tom Konikoff1,4*, Tehila Avraham2, Ella Ophir1,3 and Jacob Bornstein1,3 Abstract Background: Hyperemesis gravidarum (HG) is characterized by severe intractable nausea and vomiting in pregnancy leading to electrolyte imbalance, ketonuria, and weight loss. The cause is unknown. This study sought to investigate the prevalence and characteristics of HG in the Western Galilee in two ethnic populations and to estimate its economic burden. Methods: Data on ethnicity, age, gestational age, number of pregnancies, and length of hospitalization were collected from the medical files of all women with HG admitted to the Galilee Medical Center in 2010–2013. Findings were compared between Arabs and Jews. Prevalence was assessed relative to total number of births. Economic burden was assessed by cost of hospitalization and work days lost. Results: The cohort included 184 women, 124 Arabic (67.4 %) and 60 Jewish (32.6 %). There were 13,630 births at the medical center during the study period, for a calculated prevalence of HG of 1.2 %. There was no difference in the relative proportions of Arabs and Jews between the cohort and the total women giving birth at our center. Mean patient age was 27.2 years, gestational age 9.3 weeks, parity 2.35. Mean age was significantly higher in the Jewish group. There were no significant between-group differences in the other clinical parameters. Mean number of hospitalization days was 2.24 days, and of additional rest days prescribed, 4.62.
    [Show full text]
  • Posters - Interventional Cardiology
    P1 - Posters - Interventional Cardiology The Use of Drug Eluting Stents in Regular Clinical Practice did not Reduce the Clinical Restenosis Rate Compared to Bare Metal Stents. Diab Ghanim, Farid Naoom, Aviva Peleg, Yonathan Hasin Cardiovascular, Cardiology Department, Baroch Padeh Hospital, Tiberias, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 229 P1 - Posters - Interventional Cardiology The Impact of Diabetes Mellitus on Drug Eluting Stents Outcomes at One-year Following Acute ST Elevation Acute Myocardial Infarction Itsik Ben-Dor, Abid Assali, Hana Vaknin-Assa, Shmuel Fuchs, Eldad Rechavia, David Brosh, Eli Lev, Alexander Battler, Ran Kornowski Cardiology, Rabin Medical Center, Petach Tikva, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 230 P1 - Posters - Interventional Cardiology Urgent Coronary Catheterization in the Daily Practice: Indications and Changes Over 10 Years Khalid Suleiman, Alexander Feldman, Nahum Freedberg, Dante Antonelli, Limor Ilan- Bushari, Lev Bloch, Yoav Turgeman Heart Institute, Catheterizaion Unit, Ha'Emek Medical Center, Afula, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 231 P1 - Posters - Interventional Cardiology Late Drug Eluting Stent Thrombosis: Clinical, Angiographic and Intravascular Ultrasound Characteristics Khalid Suleiman, Limor Ilan- Bushari, Alexander Feldman, Yoav Turgeman Heart Institute, Catheterization Unit, Ha'Emek Medical Center, Afula, Israel The 55th Annual Conference of the I.H.S and the I.S.C.S 232 P1 - Posters - Interventional Cardiology
    [Show full text]
  • Past Recipients Hirsch Nursing Award
    Past Recipients Hirsch Nursing Award Year First Name Last Name Israel Institution North American Institution Area of Study 2017 Ali Abo Ali Rambam Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Limor Eisenberg Israel Ministry of Health New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Dvora Luzon Kaplan Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2017 Ben Rozenblit Meir Medical Center New York-Presbyterian Emergency Medicine Queens (NYPQ) Hospital 2016 Hilla Fighel Israel Ministry of Health Washington State Psychiatric Association of Advanced Practice Psychiatric Nurses 2016 Tmira Hefetz Clalit Health Services Washington State Psychiatric Association of Advanced Practice Psychiatric Nurses 2016 Meira Idan Psychiatric Mental Washington State Psychiatric Health Center Association of Advanced Practice Psychiatric Nurses 2016 Galit Levi Lev-Hasharon Mental Washington State Psychiatric Health Medical Center Association of Advanced Practice Psychiatric Nurses 2015 Liat Arbel Tel Aviv Sourasky Massachusetts General Pain Management Medical Center Hospital in Boston 2015 Ronit Meidan Hadassah Medical Massachusetts General Pain Management Center Hospital in Boston 2015 Hila Mendelovich Clalit Health Services Massachusetts General Pain Management Hospital in Boston 2015 Dana Oren Chaim Sheba Medical Massachusetts General Pain Management Center Hospital in Boston 2014 Limor Chen Rambam Medical Center Wexner Medical Center, Ohio Nurse Practitioner Profession
    [Show full text]